Acute Coronary Syndromes
From the Journals
Mediterranean diet linked to 24% reduction in CVD risk in women
The researchers are calling for more sex-specific research to guide clinical practice.
News
Another FDA class I recall of Cardiosave Hybrid/Rescue IABPs
The coiled cable connecting the display and base on some units may fail, causing an unexpected shutdown, without warnings or alarms to alert the...
Commentary
Clinician violence: Virtual reality to the rescue?
Workplace violence is affecting so many providers in hospital emergency departments but also throughout other parts of the hospital.
Conference Coverage
‘Keto-like’ diet linked to doubling of heart disease risk
But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.
20th Anniversary
20 years of clinical research in cardiology
“It’s unbelievable how much we’ve accomplished in the last 20 years” in cardiology, said Dr. Steven E. Nissen.
Conference Coverage
Causal AI quantifies CV risk, providing patient-specific goals
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
BIOVASC: Immediate complete revascularization beneficial in ACS
Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel...
Conference Coverage
When intravascular imaging guides complex PCI, MACE risk is lowered
In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.
Conference Coverage
Viability-guided PCI doubted in stable severe CAD: REVIVED-BCIS2
Is myocardial viability testing for guiding PCI decisions currently used in the best way? A secondary analysis from the main trial suggests not....
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...